Indication
Preterm Premature Rupture of Membrane
4 clinical trials
9 products
Clinical trial
Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation: a Double-blinded Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-11-01
Product
NifedipineClinical trial
Improvement of PPROM Management With Prophylactic Antimicrobial TherapyStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Product
CeftriaxoneProduct
ClarithromycinProduct
MetronidazoleProduct
AmpicillinProduct
AmoxicillinProduct
AzithromycinProduct
ErythromycinClinical trial
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates At-risk of Early-onset Bacterial Sepsis: a Multicentric, Randomized, Controlled, Non-inferiority Trial (the SAUNA Trial)Status: Not yet recruiting, Estimated PCD: 2027-04-15
Product
AntibioticsClinical trial
Azithromycin Pharmacokinetics and Pharmacodynamics in Pregnancy and Preterm Birth Prevention: Optimizing Dosing to Improve Maternal and Neonatal OutcomesStatus: Completed, Estimated PCD: 2020-12-27